Implementing an optimized glucose-lowering strategy with a novel once daily modified release gliclazide formulation

Yazar
Shestakova, Marina V.
Satman, Ilhan
Trubitsyna, Natalya P.
Piletic, Milivoj
Leiter, Lawrence A.
Üst veri
Tüm öğe kaydını göster
Özet
Aim: The 6-months titration profile of a new scored gliclazide modified release (MR) formulation (MR 60 mg) was explored in individuals with type 2 diabetes.
Bağlantı
http://hdl.handle.net/20.500.12627/70169
https://doi.org/10.1016/j.diabres.2015.11.001
Koleksiyonlar